SY

Shang Yin Xing Ling

Description

Shang Yin Xing Ling

Investor Profile

Shang Yin Xing Ling has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Medical.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shang Yin Xing Ling frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Sherpa Capital Entidad Gestora
Europe, Madrid, Spain, Madrid
Co-Investments: 1
China Cinda Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CC
Asia, Beijing, China, Beijing
Co-Investments: 1

Which angels does Shang Yin Xing Ling often collaborate with?

Shared Deals: 1

What are some of recent deals done by Shang Yin Xing Ling?

Kelun Biotech

Chengdu, Sichuan, China

Kelun Biotech is a biopharmaceutical company.It focuses on the research and development, production and sales of innovative drugs.

BiopharmaBiotechnologyMedical
Series BDec 30, 2022
Amount Raised: $200,000,000

Find More Investors Like Shang Yin Xing Ling

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Shang Yin Xing Ling | Pipeseed